and Surface force microscopy (SFM) provided insight into carbon implantation profiles, Surface chemical composition, roughness, and nanomechanical properties Selleck CB-839 of the surface-treated magnetic medium. The dependence Of surface modification oil the FCVA treatment conditions is discussed in the Context Of T-DYN. XPS. AFM. and SFM results. The findings of this Study demonstrate the potential of FCVA to provide overcoat-free magnetic recording media exhibiting oxidation resistance and enhanced nanomechanical properties. (C) 2009 American Institute of Physics [doi-10.1063/1.3245399]“
“Objective-To evaluate changes in serial hemograms and serum biochemical profiles in tumor-bearing
dogs undergoing daily anesthesia with propofol as an induction agent for radiation therapy.
Design-Retrospective case series.
Animals-31 dogs with cutaneous or subcutaneous malignancies over the trunk or limbs.
Procedures-Radiation therapy consisted of 18 daily treatments administered Monday
through Friday over a period of 24 days. Propofol was administered IV to effect for induction of anesthesia. Complete blood count and serum biochemical data were generated at the beginning, middle, and end of radiation therapy and compared to identify changes over time via either a CH5183284 datasheet repeated-measures ANOVA or Friedman test.
Results-Leukocyte and platelet parameters did not differ significantly over time. Calculated Hct, erythrocyte count, hemoglobin concentration, and mean corpuscular hemoglobin concentration decreased over time, whereas mean corpuscular volume increased over time.
Conclusions and Clinical Relevance-Dogs receiving propofol for induction of LY2835219 molecular weight anesthesia and radiation
therapy had a decrease in RBC count, although these changes were not determined to be of clinical importance in this patient population. The cause of these alterations was not immediately apparent. Propofol appeared to be a safe choice for induction of anesthesia in dogs during daily radiation therapy. (J Am Vet Med Assoc 2012;241:898-903)”
“Cerebral palsy will affect nearly 10% of the 60 000 very low-birth-weight infants born in the United States in the next year, and an even greater percentage will display some form of permanent neurological impairment resulting from injury to the preterm brain. The 2008 Neurobiology of Disease in Children Symposium, held in conjunction with the 37th annual meeting of the Child Neurology Society, aimed to define current knowledge and to develop specific aims for future clinical, translational, and fundamental science. A complex interplay of both destructive and developmental forces is responsible for injury to the preterm brain. Advances in imaging and histology have implicated a variety of cell types, though preoligodendrocyte injury remains the focus. Research into different mechanisms of injury is facilitating new neuroprotective and rehabilitative interventions.